Macau, China vs Switzerland: Survival to age 65, male
Macau, China
91.1%
in 2024
Switzerland
91.0%
in 2024
Macau, China rank
11th
Switzerland rank
13th
Survival to age 65, male over time
- Macau, China
- Switzerland
How they compare
Macau, China currently reports 91.1% against 91.0% in Switzerland, a difference of 0.1%.
The two have swapped places 7 times across 65 shared years of data; in 1960 it was Switzerland ahead.
Macau, China ranks 11th and Switzerland ranks 13th of 218 countries.
Across the 7 decades both report, Macau, China averaged higher in 4 and Switzerland in 3.
Head to head by decade
| Decade | Macau, China | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 1960s | 63.3% | 71.3% | 8.0% | Switzerland |
| 1970s | 71.5% | 75.1% | 3.6% | Switzerland |
| 1980s | 77.9% | 78.4% | 0.5% | Switzerland |
| 1990s | 83.4% | 82.0% | 1.4% | Macau, China |
| 2000s | 88.0% | 86.4% | 1.6% | Macau, China |
| 2010s | 90.2% | 89.6% | 0.7% | Macau, China |
| 2020s | 90.7% | 90.6% | 0.2% | Macau, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher survival to age 65, male, Macau, China or Switzerland?
- Macau, China, at 91.1% against 91.0% in Switzerland as of 2024.
- What is the difference in survival to age 65, male between Macau, China and Switzerland?
- 0.1%, with Macau, China ahead.
- How many years of comparable data are there for Macau, China and Switzerland?
- 65 years are reported by both, from 1960 to 2024.
- How do Macau, China and Switzerland rank globally for survival to age 65, male?
- Macau, China ranks 11th and Switzerland ranks 13th of 218 countries.
- Where does this data come from?
- World Population Prospects, United Nations (UN), publisher: UN Population Division, published as Survival to age 65, male (% of cohort). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Survival to age 65 refers to the percentage of a cohort of newborn infants that would survive to age 65, if subject to age specific mortality rates of the specified year.